Good News For The Weekend: a New “Old” Potential Treatment for Autism

by KJ McElrath | Aug 26, 2017 | Pharmaceutical Industry |

Until the introduction of the herbicide glyphosate (the active ingredient in Monsanto’s...

Alarming New Study Links Anti-Psychotics With Childhood Obesity

by KJ McElrath | Jul 18, 2017 | Pharmaceutical Industry |

A recently-published Canadian study involving children and teens indicates that the use of...

Department of Justice Charges 400 Individuals With Health Care Fraud: One in Four Were Peddling Opioids

by KJ McElrath | Jul 14, 2017 | Opioids, Pharmaceutical Industry |

This week saw the “largest health care fraud takedown operation” in the nation’s history,...

A Tale of Two Prescription Meds and How They Illuminate a Big Pharma Scam

by KJ McElrath | Jun 28, 2017 | Pharmaceutical Industry |

Individually, they’re pretty inexpensive. Put them together, however, and they become worth...

Amidst Controversies Surrounding ADHD Medication Safety, a Pharmaceutical Company Comes Up With “Chewable” Meds. Is This a Good Idea?

by KJ McElrath | Jun 23, 2017 | Pharmaceutical Industry |

At a time when the use and overuse of amphetamine and methylphenidate-based medications among...

The “Fairness in Class Action Litigation Act” Will Make it More Difficult to Hold Pharmaceutical Companies Accountable

by KJ McElrath | May 24, 2017 | Pharmaceutical Industry |

Even when companies like Johnson & Johnson, Bayer, Daichii Sankyo and others are found liable...